The role of MMAC1 mutations in early-onset breast cancer: Causative in association with Cowden Syndrome and excluded in BRCA/-negative cases

American Journal of Human Genetics

Volumn 61, Issue 5, 1997, Pages 1036-1043

  Tsou, Hui C ^a   Teng, David H F ^c   Ping, Xiao Li ^a   Brancolini, Valeria ^b   Davis, Thaylon ^c   Hu, Rong ^c   Xie, Xiao Xun ^a   Gruener, Alexandra C ^a   Schrager, Carolina A ^a   Christiano, Angela M ^a   Eng, Charis ^d   Steck, Peter ^e   Ott, Jurg ^b   Tavtigian, Sean V ^c   Peacocke, Monica ^a,f  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c Utah   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f Department of Orthopaedic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; CHROMOSOME 10; CLINICAL FEATURE; COWDEN SYNDROME; DISEASE ASSOCIATION; FEMALE; GENE LOCATION; GENE MUTATION; GENETIC LINKAGE; GERM LINE; HAMARTOMA; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL;

EID: 16944362877     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301607     Document Type: Article

References (24)

1. Albrecht S, Haber RM, Goodman JC, Duvic M (1992) Cowden syndrome and Lhermitte-Duclos syndrome. Cancer 70: 869-875
2. Brownstein MH, Mehgregan AH, Bikowski J (1977) Trichilemmomas in Cowden's syndrome. JAMA 238:26
3. Brownstein MH, Wolf M, Bikowski JB (1978) Cowden's syndrome - a cutaneous marker of breast cancer. Cancer 41: 2393-2398
4. Claus EB, Risch NJ, Thompson WD (1990) Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 131:961-972
5. Ford D, Easton DF, Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57:1457-1462
6. Fornander T, Rutqvist LE, Cedermark B, Glas U, Mattsson A, Silfversward C, Skoog L, et al (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1:117-120
7. Haines JL, Short MP, Kwiatkowski DJ, Jewell A, Andermann E, Bejjani B, Yang C-H, et al (1991) Localization of one gene for tuberous sclerosis within 9q32-9q34 and further evidence for heterogeneity. Am J Hum Genet 49:764-772
8. Kandt RS, Haines JL, Smith M, Northrup H, Gardner RJ, Short MP, Dumars K, et al (1992) Linkage of an important locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 2:37-41
9. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES (1996) Parametric and nonparametric linkage anlaysis: a unified multipoint approach. Am J Hum Genet 58:1347-1363
10. Lathrop GM, Lalouel JM, Juller C, Ott J (1984) Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 81:3443-3446
11. Li D-M, Sun H (1997) TEP1, encoded by a candidate tumor suppressor locus, is a novel tyrosine phosphatase regulated by transfroming growth factor β. Cancer Res 57:2124-2129
12. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Pue J, et al (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947
13. Liaw D, Marsh D, Li J, Dahia PLM, Wang S, Zheng Z, Puc Z, et al (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64-67
14. Lloyd KM, Dennis M (1963) Cowden's syndrome: a possible new symptom complex with multiple system involvement. Ann Intern Med 58:136-142
15. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, et al (1994) A strong candidate gene for the breast and ovarian cancer susceptibility gene. Science 266:66-71
16. Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, et al (1996) Localization of the gene for Cowden disease to 10q22-23. Nat Genet 13: 114-116
17. Schrager CA, Schneider D, Gruener AC, Tsou HC, Peacocke M. Clinical and pathological features of breast cancer in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer. Hum Pathol (in press)
18. Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D. Complete DNA sequence analysis of BRCA1 in 798 women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing. JAMA (in press)
19. Starink TM, Van Der Veen JPW, Arwert F, De Waal LP, De Lange GG, Gille JP, Eriksson AW (1986) The Cowden's syndrome: a clinical and genetic study in 21 patients. Clin Genet 29:222-233
20. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA (1997) Identification of a candidate tumour suppressor gene, MAMC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362
21. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked families. Nat Genet 12:333-337
22. Walton BJ, Morain WB, Baughman RD, Jordan A, Crichlow RW (1986) A further indication for prophylactic mastectomy. Surgery 99:82-86
23. Weary PE, Gorlin RJ, Gentry WC, Comer JE, Greer K (1972) Multiple hamartoma syndrome (Cowden's syndrome). Arch Dermatol 106:682-690
24. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792